Filters

Upadacitinib manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

upadacitinib

Tablets, extended release (ER) 15 mg, 30 mg, 45 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
Reference product: Rinvoq®
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 29 days

upadacitinib

Tablets, extended release (ER) 15 mg, 30 mg, 45 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, EU GMP, Canada
Manufacturer #10897
A pharmaceutical manufacturer based in Asia that is active in 80+ countries selling its products in Europe, North America, Africa, the Middle East, CIS, LATAM, and Asia for 40+ years. The company's production lines are WHO GMP-compliant. The main dosage forms are tablets, capsules, dry syrups, suspensions, and injections. The main therapeutic areas include antifungal, analgesics, and psychotropics.

Manufacturer usually replies in 61 days

upadacitinib

Tablets, extended release (ER) 15 mg, 30 mg, 45 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
India
Manufacturer #16857
A pharmaceutical manufacturer with integrated capabilities in active pharmaceutical ingredients, intermediates, and finished formulations, supplying pharmaceutical products to global partners across key therapy areas such as diabetes, cardiac care, neurology, anti-bacterial and anti-fungal segments. The organisation highlights strong in-house R&D, backward integration into intermediates and APIs, and scalable manufacturing from development to multi-ton commercial output. For quality, the site states that its formulation manufacturing operates in a GMP-compliant facility recognised by major regulators, and specifically lists approvals/recognition including USFDA, EU-GMP, WHO and TGA, supporting reliable international supply of pharmaceutical products.

Manufacturer usually replies in 28 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.